Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)
Clinical trial NCT04029116 · COMPLETED
Trial details
- NCT number
- NCT04029116
- Sponsor
- Scynexis, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-21
- Primary completion
- 2021-09-01
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.